您的位置: 首页 > 农业专利 > 详情页

Peptide-Based In Vivo siRNA Delivery System
专利权人:
David B. Rozema;Jonathan D. Benson;Jon A. Wolff;H;Darren H. Wakefield;Peter Mohr;Eric A. Kitas;Kerstin Jahn-Hofmann;Jeffrey C. Carlson;David L. Lewis;Torsten Hoffman;Philipp Hadwiger;Andrei V. Blokhin
发明人:
David B. Rozema,Darren H. Wakefield,David L. Lewis,Jon A. Wolff,Andrei V. Blokhin,Jonathan D. Benson,Jeffrey C. Carlson,Philipp Hadwiger,Eric A. Kitas,Torsten Hoffman,Kerstin Jahn-Hofmann,Peter Mohr,H
申请号:
US13326433
公开号:
US20120165393A1
申请日:
2011.12.15
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to hepatocytes in vivo. Targeted RNAi polynucleotides are administered together with co-targeted melittin delivery peptides. Delivery peptides provide membrane penetration function for movement of the RNAi polynucleotides from outside the cell to inside the cell. Reversible modification provides physiological responsiveness to the delivery peptides.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充